Trial was the first to test a drug meant to delay or halt mental decline in people who have a genetic predisposition
Relative change from 2016 to 2019 varied from −52.0 percent in Mississippi to −6.9 percent in New Hampshire
At pandemic outset, significant decreases in buprenorphine prescription fills seen for Black, Hispanic patients, but not White patients
Risks for ASD, intellectual disability may be increased with prenatal exposure to topiramate, valproate, certain duotherapies
Pharmacotherapy for alcohol use disorder linked to reduced incidence of hepatic decompensation in patients with cirrhosis
Model based on six clinical predictors explained 61.4 and 49.8 percent of variance in body clearance of lithium, respectively, in two cohorts
Survey of 126 clinicians helps pinpoint barriers to obtaining waivers, prescribing buprenorphine
Yet, study shows buprenorphine is effective in protecting against overdose in this population
Extrapolation of the findings from pivotal clinical trials to the approved indication most common for disease severity
Commonly prescribed antipsychotic medications taken late in pregnancy seem not to meaningfully increase NDD risk in offspring